Cargando…
Small-Molecule Therapeutic Perspectives for the Treatment of Progeria
Hutchinson–Gilford progeria syndrome (HGPS), or progeria, is an extremely rare disorder that belongs to the class of laminopathies, diseases characterized by alterations in the genes that encode for the lamin proteins or for their associated interacting proteins. In particular, progeria is caused by...
Autores principales: | Macicior, Jon, Marcos-Ramiro, Beatriz, Ortega-Gutiérrez, Silvia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8267806/ https://www.ncbi.nlm.nih.gov/pubmed/34281245 http://dx.doi.org/10.3390/ijms22137190 |
Ejemplares similares
-
Isoprenylcysteine Carboxylmethyltransferase-Based
Therapy for Hutchinson–Gilford Progeria Syndrome
por: Marcos-Ramiro, Beatriz, et al.
Publicado: (2021) -
New treatments for progeria
por: Villa-Bellosta, Ricardo
Publicado: (2019) -
Progeria
Publicado: (1935) -
A small-molecule ICMT inhibitor delays senescence of Hutchinson-Gilford progeria syndrome cells
por: Chen, Xue, et al.
Publicado: (2021) -
Living with Progeria
por: Stamsnijder, Marjet
Publicado: (2010)